Early-stage breast cancer detection in breast milk

Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer

A reproducibility study in pulmonary adenocarcinomas supports a revised classification

OncoAlert Round Up for September 1-7, 2023

Part 6: Which different PARP inhibitors are available

Part 7: Similarities and Differences

Part 8: How PARP inhibitors are being used now

Part 9: What PARP inhibitors mean for the future and what to look out for

Update from ASCO Breakthrough Asia Conference 2023

The impact of SEABCS 2023

OncoAlert Round Up for August 18th - 24th, 2023

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours